Paratus Sciences

We navigate evolutionary data to translate extreme biological adaptations into first-in-class medicines. Learn more about our process.

Health and bio

Funding rounds

1. March 8, 2023
   Series A · $100M
   AARCH Venture Partners (lead), CClavystBio (lead), EEcoR1 Capital (lead), LLeaps by Bayer (lead), PPolaris (lead), AAlexandria Venture Investments
   Source: startupintros.com
2. April 15, 2021
   Website created

Founders and team

• PM
  Paul Matsudaira Co-founder, Paratus

  LinkedIn · source: paratussciences.com
• RY
  Richard Young Co-founder, Paratus

  @youngricka · LinkedIn · source: paratussciences.com
• TZ
  Thomas Zwaka Founder

  @tomek_1234 · LinkedIn
• AS
  Alicia Secor President and CEO

Investors

• AAlexandria Venture Investments
• AARCH Venture Partnerslead investor
• CClavystBiolead investor
• EEcoR1 Capitallead investor
• LLeaps by Bayerlead investor
• PPolarislead investor

Companies like Paratus Sciences

• MModel Medicines$4.1M · Nov 2021
• TTargED BiopharmaceuticalsSeries A · Jul 2025
• MMemo Therapeutics$22M Series B+ · May 2024
• MMyosin Therapeutics$3M Seed · Mar 2025
• OOncusp TherapeuticsSeries A · Nov 2025
• LLifeMine Therapeutics$75M Series B+ · Aug 2026

Other companies backed by ARCH Venture Partners

• Bbit.bio$25M Series B+ · Nov 2026
• SSoufflé Therapeutics$135M Series B+ · Oct 2026
• OOratomic$475M Series B+ · Oct 2026
• LLifeMine Therapeutics$75M Series B+ · Aug 2026
• SSynchron$275M Series B+ · Jun 2026
• LLightcast$27M Series B+ · Apr 2026

ARCH Venture Partners portfolio →